To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.


We, the EBCI Board of Directors, Staff, Contract Employees and Volunteers, strive toward excellence as an organization, laser-focused on advancing our unique mission. We are advancing efforts to make Brain Cancer a manageable disease, through the acceleration of access to promising new therapies and treatments based on science. We are assertive in our endeavor, with positive and collaborative attitudes, while open to all manners of ideas and feedback, and a willingness to “go the extra mile”. We will always prioritize the underserved Brain Cancer community with full respect to the diversity of our patient, caregiver, clinician, and researcher population, and fully embrace inclusion and equity in access to disease education, therapies, and treatments.

Our company culture motivates team members to give their full selves to the mission and invest in their own and in the company’s future. We will always remain true to our approach of being personable, respectful, and compassionate toward our communities and corporate partners. We will listen without pretense nor egos to better understand and adapt our programs and offerings to best support our community populations. We acknowledge the burden of this disease and actively encourage joy and lightheartedness as appropriate. We intentionally carve out time to celebrate our individual and collective milestones and successes.

We are enthusiastically evolving and are not yet the Board of Governance and Advisors that we would ideally be, in fact, we roll up our sleeves daily to get the job done and to lend our expertise in moving our organization forward.


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram